Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Metabolic bone disease and bone quality].

Shinsuke Yamada¹, Masaaki Inaba, Yoshiki Nishizawa

¹Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.

Clinical Calcium

|December 4, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Author's Reply to the Letter to the Editor: Is the "Nutritional Risk Index for Japanese Hemodialysis" Validated as a Nutritional and Prognostic Indicator?

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2024

Same author

Association of Nutritional Risk Index With Infection-Related Hospitalization and Death After Hospitalization in Patients Undergoing Maintenance Hemodialysis.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2024

Same author

Evolution of cooperation in multiplex networks through asymmetry between interaction and replacement.

Scientific reports·2023

Same author

Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes.

Journal of atherosclerosis and thrombosis·2023

Same author

Associations of time-dependent changes in phosphorus levels with cardiovascular diseases in patients undergoing hemodialysis: results from the Japan Dialysis Active Vitamin D (J-DAVID) randomized clinical trial.

Clinical kidney journal·2022

Same author

Effects of alfacalcidol on cardiovascular outcomes according to alkaline phosphatase levels in the J-DAVID trial.

Scientific reports·2022

Bone strength depends on bone volume, measured by bone mineral density (BMD). However, bone quality and microstructure also significantly impact bone strength in metabolic bone diseases like osteoporosis.

Area of Science:

Orthopedics and Bone Biology
Metabolic Bone Disease Research

Context:

Osteoporosis diagnosis and treatment efficacy traditionally rely on bone mineral density (BMD) measurements using dual-energy X-ray absorptiometry (DXA).
Bone strength is largely attributed to bone volume, which is assessed via BMD.

Purpose:

To outline the changes in bone quality associated with metabolic bone diseases.
To highlight the importance of bone microstructure beyond BMD in assessing bone health.

Summary:

While BMD is a key determinant of bone strength, advances in bone morphometry reveal that bone quality, particularly microstructure, also plays a crucial role.
Metabolic bone diseases, including osteoporosis, involve not only reduced BMD but also deterioration of bone microarchitecture.

Related Experiment Videos

Impact:

This understanding is critical for accurate diagnosis and effective treatment strategies for metabolic bone diseases.
Emphasizes the need to consider both bone quantity (BMD) and bone quality (microstructure) for comprehensive bone health assessment.